NCT07019285Completed
Interval Training and Plasma Volume Variation
Comparative Effects of High- vs. Moderate Intensity Interval Walking Training on Plasma Volume Variations, Hematological and Muscle-Damage Markers in Overweight/Obese Postmenopausal Women
Source: ClinicalTrials.gov · Last updated 17 Jun 2025
Brief summary (registry, in English)
The goal of this clinical trial is to to compare the effects of high (HIIWT) versus moderate-intensity interval walking training (MIIWT) on body composition, plasma volume variations (PVV), hematological parameters, muscle damage and aerobic capacity in overweight/obese postmenopausal women. The main question it aims to answer is:Does HIIWT and MIIWT improve kidney function markers in this population? Researchers will compare HIIWT to MIIWT and to non-training intervention(designed to control group) to see if the training program at different intensities work to improve kidney function markers. Participants in HIIWT group will: perform a 8-week HIIWT program, three sessions per week (5 repetitions of 6-min-walking-test (6MWT) at 90-110% of 6MWTdistance measured at baseline, interspersed by 6-min of active recovery between repetitions). Participants in MIIWT group will: perform a 8-week MIIWT program, three sessions per week (5 repetitions of 6-min-walking-test (6MWT) at 60-80% of 6MWTdistance measured at baseline, interspersed by 6-min of active recovery between repetitions). Participants in control group will : not perform any physical training and maintain their usual daily activities.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 26 May 2025
- Start date
- 6 Jan 2025
- Primary completion date
- 16 Mar 2025
- Lead sponsor
- Wissal Abassi
- Diseases
- Obesity
- NCT number
- NCT07019285
What you commit to
- Study type: Interventional
- Participants enrolled: 32
- From 6 Jan 2025 to the primary completion date, 16 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current use of hormone replacement therapy or any prescribed medication.
Other illness
- Medical contraindications to physical activity, diagnosed metabolic, hormonal, orthopedic, or cardiovascular conditions.
Who the study is looking for
- Age range of 45-59 years.
- Postmenopausal women (cessation of menses for at least 12 consecutive months).
- Body mass index (BMI) ≥ 25 kg/m2.
- Body weight remained constant (±2 kg) during the past 3 months.
- Stable eating habits and physical activity for at least 3 months.
- Sedentary lifestyle (exercise less than 1h/week).
Age in the registry: 45 years to 59 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| High Institute of Sports and Physical Education of Kef Coordinator of this site? Confirm its status | El Kef | Tunisia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.